Octarine Bio is a Denmark-based startup founded in 2018 with a clear mission encapsulated in their slogan, "We're harnessing nature to drive sustainable solutions." The company is focused on pioneering new sustainable bio-based ingredients within the Biopharma, Biotechnology, and Health Care sectors.
Their recent €4.35M Series A investment on 08 November 2023 has attracted notable investors including DSM Venturing, Unconventional Ventures, The Footprint Firm, and Oskare Capital. This investment is a clear indication of the confidence and belief that key players in the market have in the potential of Octarine Bio and their innovative approach to sustainable solutions.
With a strong emphasis on harnessing the power of nature, Octarine Bio is strategically positioned to make a significant impact in the biopharma and biotechnology spaces. The recent investment serves as a testament to the company's potential for growth and a validation of their endeavors to pioneer sustainable and bio-based ingredients.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | €4.35M | 4 | 08 Nov 2023 | |
Seed Round | €2.00M | 2 | 20 Sep 2022 | |
Seed Round | $1.20M | 2 | 11 Mar 2021 | |
Seed Round | $1.80M | 4 | Bruce Linton | 12 Nov 2020 |
Non Equity Assistance | Unknown | 1 | 21 Oct 2020 |